Recurrent Triple-Negative Breast Cancer
1 clinical trials · Condition
◉ Watch Recurrent Triple-Negative Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab + Paclitaxel +/- Bevacizumab for Triple-negative Breast Cancer (NCT06976944) | Yukinori Ozaki | 2025-06-24 |
Track Recurrent Triple-Negative Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.